GRIO


ROUX

Pr Christian ROUX

Comité scientifique du GRIO


Présentation > Les membres du Comité Directeur > Pr Christian ROUX > Publications

PUBLICATIONS RÉCENTES


Briot K, Roux C. Drug-induced osteoporosis: beyond glucocorticoids. Curr Rheumatol Rep. 2008;10(2):102-9

Rolland Y, Abellan Van Kan G, Benetos A, Blain H, Bonnefoy M, Chassagne P, Jeandel C, Laroche M, Nourhashémi F, Orcel P, Piette F, Ribot C, Ritz P, Roux C, Taillandier J, Tremollieres F, Weryha G, Vellas B. Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. J Nutr Health Aging. 2008;12(5):335-46

Roux C. Selecting first-line treatment for patients with osteoporosis. Joint Bone Spine. 2008;75(3):257-9. Epub 2008 18.

Geusens PP, Roux CH, Reid DM, Lems WF, Adami S, Adachi JD, Sambrook PN, Saag KG, Lane NE, Hochberg MC. Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspective. Nat Clin Pract Rheumatol. 2008;4(5):240-8. Epub 2008 8

El Maghraoui A, Roux C. DXA scanning in clinical practice. QJM. 2008 10. [Epub ahead of print]

Lespessailles E, Gadois C, Kousignian I, Neveu JP, Fardellone P, Kolta S, Roux C, Do-Huu JP, Benhamou CL. Clinical interest of bone texture analysis in osteoporosis: a case control multicenter study. Osteoporos Int. 2008 15. [Epub ahead of print]

Boonen S,in F, Obermayer-Pietsch B, Simões ME, Barker C, Glass EV, Hadji P, Lyritis G, Oertel H, Nickelsen T, McCloskey EV; EUROFORS Investigators. Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis. J Clin Endocrinol Metab. 2008;93(3):852-60. Epub 2007 26

Cotté FE, Cortet B, Lafuma A, Avouac B, Hasnaoui AE, Fardellone P, Pouchain D, Roux C, Gaudin AF. A model of the public health impact of improved treatment persistence in post-menopausal osteoporosis in France. Joint Bone Spine. 2008;75(2):201-8. Epub 2007 Aug 31

Bruyère O, Roux C, Badurski J, Isaia G, de Vernejoul MC, Cannata J, Ortolani S, Slosman D, Detilleux J, Reginster JY. Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate. Curr Med Res Opin. 2007;23(12):3041-5

Bruyère O, Delferriere D, Roux C, Wark JD, Spector T, Devogelaer JP, Brixen K, Adami S, Fechtenbaum J, Kolta S, Reginster JY. Effects of strontium ranelate on spinal osteoarthritis progression. Ann Rheum Dis. 2008;67(3):335-9. Epub 2007 26

Marquis P, Roux C, de la Loge C, Diaz-Curiel M, Cormier C, Isaia G, Badurski J, Wark J, Meunier PJ. Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis. Osteoporos Int. 2008;19(4):503-10. Epub 2007 11

Arlot ME, Jiang Y, Genant HK, Zhao J, Burt-Pichat B, Roux JP, Delmas PD, Meunier PJ. Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate. J Bone Miner Res. 2008;23(2):215-22

Berarducci A. Bone loss. An emerging problem following obesity surgery. Orthop Nurs. 2007 Sep-Oct;26(5):281-6; quiz 287-8

Delmas PD, McClung MR, Zanchetta JR, Racewicz A, Roux C, Benhamou CL, Man Z, Eusebio RA, Beary JF, Burgio DE, Matzkin E, Boonen S. Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis. Bone. 2008;42(1):36-42. Epub 2007 Sep 8

Chapurlat RD, Arlot M, Burt-Pichat B, Chavassieux P, Roux JP, Portero-Muzy N, Delmas PD. Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: a bone biopsy study. J Bone Miner Res. 2007;22(10):1502-9

Abitbol V, Briot K, Roux C, Roy C, Seksik P, Charachon A, Bouhnik Y, Coffin B, Allez M, Lamarque D, Chaussade S. A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5(10):1184-9. Epub 2007 Aug 1

Roux C, Fechtenbaum J, Kolta S, Briot K, Girard M. Mild prevalent and incident vertebral fractures are risk factors for new fractures. Osteoporos Int. 2007;18(12):1617-24. Epub 2007 Jul 5

Bruyere O, Roux C, Detilleux J, Slosman DO, Spector TD, Fardellone P, Brixen K, Devogelaer JP, Diaz-Curiel M, Albanese C, Kaufman JM, Pors-Nielsen S, Reginster JY. Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J Clin Endocrinol Metab. 2007 Aug;92(8):3076-81. Epub 2007 Jun 12

Roux C, Fechtenbaum J, Briot K, Cropet C, Liu-Léage S,celli C. Inverse relationship between vertebral fractures and spine osteoarthritis in postmenopausal women with osteoporosis. Ann Rheum Dis. 2008;67(2):224-8. Epub 2007 Jun 8

Ferrar L, Jiang G, Armbrecht G, Reid DM, Roux C, Glüer CC, Felsenberg D, Eastell R. Is short vertebral height always an osteoporotic fracture? The Osteoporosis and Ultrasound Study (OPUS). Bone. 2007 Jul;41(1):5-12. Epub 2007 4

Ruyssen-Witrand A, Gossec L, Kolta S, Dougados M, Roux C. Vertebral dimensions as risk factor of vertebral fracture in osteoporotic patients: a systematic literature review. Osteoporos Int. 2007 Sep;18(9):1271-8. Epub 2007 6

Bassett JH, O'Shea PJ, Sriskantharajah S, Rabier B, Boyde A, Howell PG, Weiss RE, Roux JP, Malaval L, Clement-Lacroix P, Samarut J, Chassande O, Williams GR. Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. Mol Endocrinol. 2007;21(5):1095-107. Epub 2007 27

Roux C, Briot K, Horlait S, Varbanov A, Watts NB, Boonen S. Assessment of non-vertebral fracture risk in postmenopausal women. Ann Rheum Dis. 2007 Jul;66(7):931-5. Epub 2007 21

Delmas PD, Vrijens B, Eastell R, Roux C, Pols HA, Ringe JD, Grauer A, Cahall D, Watts NB; Improving Measurements of Persistence on Actonel Treatment (IMPACT) Investigators. Effect of monitoring bone turnoverkers on persistence with risedronate treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab. 2007;92(4):1296-304. Epub 2007 23. Erratum in: J Clin Endocrinol Metab. 2007 Jun;92(6):2285

Briot K, Trémollières F, Thomas T, Roux C; Comité scientifique du GRIO. How long should patients take medications for postmenopausal osteoporosis? Joint Bone Spine. 2007;74(1):24-31. Epub 2006 4

Le Bras A, Kolta S, Soubrane P, Skalli W, Roux C, Mitton D. Assessment of femoral neck strength by 3-dimensional X-ray absorptiometry. J Clin Densitom. 2006-Dec;9(4):425-30. Epub 2006 Sep 28

Viguet-Carrin S, Roux JP, Arlot ME, Merabet Z, Leeming DJ, Byrjalsen I, Delmas PD, Bouxsein ML. Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae. Bone. 2006;39(5):1073-9. Epub 2006 Jul 10

Roux C, Priol G, Fechtenbaum J, Cortet B, Liu-Léage S, Audran M. A clinical tool to determine the necessity of spine radiography in postmenopausal women with osteoporosis presenting with back pain. Ann Rheum Dis. 2007;66(1):81-5. Epub 2006 Jun 22

Damiano J, Kolta S, Porcher R, Tournoux C, Dougados M, Roux C. Diagnosis of vertebral fractures by vertebral fracture assessment. J Clin Densitom. 2006;9(1):66-71. Epub 2006 27

Stewart A, Felsenberg D, Eastell R, Roux C, Glüer CC, Reid DM. Relationship between risk factors and QUS in a European Population: The OPUS study. Bone. 2006 Sep;39(3):609-15. Epub 2006 27

Roux C, Reginster JY, Fechtenbaum J, Kolta S, Sawicki A, Tulassay Z, Luisetto G, Padrino JM, Doyle D, Prince R, Fardellone P, Sorensen OH, Meunier PJ. Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors. J Bone Miner Res. 2006;21(4):536-42. Epub 2006 5

Briot K, Roux C. What is the role of DXA, QUS and bonekers in fracture prediction, treatment allocation and monitoring? Best Pract Res Clin Rheumatol. 2005;19(6):951-64

Soubrier M, Roux C. Statins in rheumatology. Joint Bone Spine. 2006;73(2):159-68. Epub 2005 11

Miller PD, Roux C, Boonen S, Barton IP, Dunlap LE, Burgio DE. Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res. 2005;20(12):2105-15. Epub 2005 Aug 22

de la Loge C, Sullivan K, Pinkney R,quis P, Roux C, Meunier PJ. Cross-cultural validation and analysis of responsiveness of the QUALIOST: QUAlity of Life questionnaire In OSTeoporosis. Health Qual Life Outcomes. 2005 10;3:69

Fechtenbaum J, Cropet C, Kolta S, Horlait S, Orcel P, Roux C. The severity of vertebral fractures and health-related quality of life in osteoporotic postmenopausal women. Osteoporos Int. 2005;16(12):2175-9. Epub 2005 12

Portero NR, Arlot ME, Roux JP, Duboeuf F, Chavassieux PM, Meunier PJ. Evaluation and development of automatic two-dimensional measurements of histomorphometric parameters reflecting trabecular bone connectivity: correlations with dual-energy x-ray absorptiometry and quantitative ultrasound in human calcaneum. Calcif Tissue Int. 2005;77(4):195-204. Epub 2005 Sep 28

Ea HK, Blanchard A, Dougados M, Roux C. Chondrocalcinosis secondary to hypomagnesemia in Gitelman's syndrome. J Rheumatol. 2005 Sep;32(9):1840-2

Fechtenbaum J, Cropet C, Kolta S, Verdoncq B, Orcel P, Roux C. Reporting of vertebral fractures on spine X-rays. Osteoporos Int. 2005;16(12):1823-6. Epub 2005 Jul 20

Mayoux-Benhamou MA, Roux C, Perraud A, Fermanian J, Rahali-Kachlouf H, Revel M. Predictors of compliance with a home-based exercise program added to usual medical care in preventing postmenopausal osteoporosis: an 18-month prospective study. Osteoporos Int. 2005;16(3):325-31. Epub 2004 Jul 29

De Prisco C, Levine SN. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci. 2005;329(2):57-61

Roux C, Garnero P, Thomas T, Sabatier JP, Orcel P, Audran M; Comité Scientifique du GRIO. Recommendations for monitoring antiresorptive therapies in postmenopausal osteoporosis. Joint Bone Spine. 2005;72(1):26-31

Padilla F, Akrout L, Kolta S, Latremouille C, Roux C, Laugier P. In vitro ultrasound measurement at the human femur. Calcif Tissue Int. 2004;75(5):421-30. Epub 2004 Jun 17

Falgarone G, Porcher R, Duché A, Kolta S, Dougados M, Roux C. Discrimination of osteoporotic patients with quantitative ultrasound using imaging or non-imaging device. Joint Bone Spine. 2004;71(5):419-23

Mellström DD, Sörensen OH, Goemaere S, Roux C, Johnson TD, Chines AA. Seven years of treatment with risedronate in women with postmenopausal osteoporosis. Calcif Tissue Int. 2004;75(6):462-8. Epub 2004 7

Collazo-Clavell ML, Jimenez A, Hodgson SF, Sarr MG. Osteomalacia after Roux-en-Y gastric bypass. Endocr Pract. 2004;10(3):195-8

von Mach MA, Stoeckli R, Bilz S, Kraenzlin M, Langer I, Keller U. Changes in bone mineral content after surgical treatment of morbid obesity. Metabolism. 2004;53(7):918-21

Laugier P, Lefebvre F, Chappard C, Roux C. Segmentation of quantitative ultrasonographic images of the calcaneus using elastic deformation of the flexible Fourier contour. J Ultrasound Med. 2004;23(5):693-9

Roux C, Seeman E, Eastell R, Adachi J, Jackson RD, Felsenberg D, Songcharoen S, Rizzoli R, Di Munno O, Horlait S, Valent D, Watts NB. Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin. 2004;20(4):433-9

Glüer CC, Eastell R, Reid DM, Felsenberg D, Roux C, Barkmann R, Timm W, Blenk T, Armbrecht G, Stewart A, Clowes J, Thomasius FE, Kolta S. Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS Study. J Bone Miner Res. 2004;19(5):782-93. Epub 2004 1

Grados F, Marcelli C, Dargent-Molina P, Roux C, Vergnol JF, Meunier PJ, Fardellone P. Prevalence of vertebral fractures in French women older than 75 years from the EPIDOS study. Bone. 2004;34(2):362-7.

Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med. 2004;350(5):459-68

Roux C, Arabi A, Porcher R, Garnero P. Serum leptin as a determinant of bone resorption in healthy postmenopausal women. Bone. 2003;33(5):847-52.

Roux C, Kolta S, Desfougeres JL, Minini P, Bidat E. Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma. Pediatrics. 2003 Jun;111:706-13.

Kolta S, De Vernejoul MC, Meneton P, Fechtenbaum J, Roux C. Bone mineral measurements in mice: comparison of two devices. J Clin Densitom. 2003 ;6(3):251-8.

Arabi A, Garnero P, Porcher R, Pelissier C, Benhamou CL, Roux C. Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study. Hum Reprod. 2003 ;18(8):1747-52.

Bruyere O, Collette J, Delmas P, Rouillon A, Roux C, Seidel L, Richy F, Reginster JY. Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women. Maturitas. 2003;44(4):259-65.

Demis E, Roux C, Breban M, Dougados M. Infliximab in spondylarthropathy--influence on bone density. Clin Exp Rheumatol. 2002 Nov-Dec;20(6 Suppl 28):S185-6.

Reginster JY, Deroisy R, Dougados M, Jupsin I, Colette J, Roux C. Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial. Osteoporos Int. 2002;13(12):925-31.

Roux C, Pelissier C, Fechtenbaum J, Loiseau-Peres S, Benhamou CL. Randomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss. Osteoporos Int. 2002;13(3):241-8

Abitbol V, Mary JY, Roux C, Soule JC, Belaiche J, Dupas JL, Gendre JP, Lerebours E, Chaussade S. Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride. Aliment Pharmacol Ther. 2002;16(5):919-27

Roux C, Dougados M. Calcitonin in glucocorticoid-induced osteoporosis. Front Horm Res. 2002;30:145-9

Lejus C, Delaroche O, Le Roux C, Legendre E, Rivault O, Floch H, Renaudin M, Pinaud M. Does sevoflurane inhibit serum cholinesterase in children? Anaesthesia. 2002 Jan;57(1):44-8

Borderie D, Roux C, Toussaint B, Dougados M, Ekindjian OG, Cherruau B. Variability in urinary excretion of bone resorption markers: limitations of a single determination in clinical practice. Clin Biochem. 2001;34(7):571-7

Boyanov MA, Popivanov PR, Roux C. Separate assessment of forearm cortical and trabecular bone density from standard densitometry data. Ann Med. 2001;33(7):497-506

Bernard-Poenaru O, Roux C, Blanque R, Gardner C, de Vemejoul MC, Cohen-Solal ME. Bone-resorbing cytokines from peripheral blood mononuclear cells after hormone replacement therapy: a longitudinal study. Osteoporos Int. 2001;12(9):769-76

Grados F, Roux C, de Vernejoul MC, Utard G, Sebert JL, Fardellone P. Comparison of four morphometric definitions and a semiquantitative consensus reading for assessing prevalent vertebral fractures.
Osteoporos Int. 2001;12(9):716-22.

Maillefert JF, Aho LS, El Maghraoui A, Dougados M, Roux C. Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study.
Osteoporos Int. 2001;12(7):605-9.

Roux C, Roberjot V, Porcher R, Kolta S, Dougados M, Laugier P. Ultrasonic backscatter and transmission parameters at the os calcis in postmenopausal osteoporosis. J Bone Miner Res. 2001;16(7):1353-62.

Roux C. Do osteoporotic vertebral deformities deserve medical attention? Joint Bone Spine. 2001;68(3):194-7.

Reginster JY, Christiansen C, Roux C, Fechtenbaum J, Rouillon A, Tou KP. Intermittent cyclic tiludronate in the treatment of osteoporosis. Osteoporos Int. 2001;12(3):169-77.

Alexandersen P, Toussaint A, Christiansen C, Devogelaer JP, Roux C, Fechtenbaum J, Gennari C, Reginster JY. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA. 2001 21;285(11):1482-8

Roux C. Can practitioners use the WHO definition for osteoporosis? Joint Bone Spine. 2001;68(1):10-1
McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001 1;344(5):333-40

Kolta S, Ravaud P, Fechtenbaum J, Dougados M, Roux C. Follow-up of individual patients on two DXA scanners of the same manufacturer. Osteoporos Int. 2000;11(8):709-13

Dernière mise à jour : 17-01-2017